Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-26-002949
Filing Date
2026-01-09
Accepted
2026-01-09 16:30:24
Documents
1
Period of Report
2026-01-07

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3786
  Complete submission text file 0001213900-26-002949.txt   5386
Mailing Address C/O CLOVIS ONCOLOGY, INC. 499 ILLINOIS STREET, SUITE 200 SAN FRANCISCO CA 94158
Business Address
Rolfe Lindsey (Reporting) CIK: 0001650504 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40877 | Film No.: 26523405

Mailing Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080 650-407-2376
CERO THERAPEUTICS HOLDINGS, INC. (Issuer) CIK: 0001870404 (see all company filings)

EIN.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)